# Start or STop Anticoagulants Randomised Trial (SoSTART)

> **NCT03153150** · PHASE3 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 203 (actual)

## Conditions studied

- Intracranial Hemorrhages
- Intracranial Hemorrhage, Hypertensive
- Subarachnoid Hemorrhage
- Subdural Hematoma
- Intraventricular Hemorrhage
- Atrial Fibrillation
- Atrial Flutter
- Small Vessel Cerebrovascular Disease
- Microhaemorrhage

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Rivaroxaban
- **DRUG:** Edoxaban
- **DRUG:** Dabigatran
- **DRUG:** Acenocoumarol
- **DRUG:** Phenindione
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT03153150
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-28
- **Primary completion:** 2021-03-26
- **Final completion:** 2021-03-26
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2022-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03153150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03153150, "Start or STop Anticoagulants Randomised Trial (SoSTART)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03153150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*